Apollon Financial’s CME Group CME Stock Holding History

Apollon Financial’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-741	Closed	-$202K	–	263
2025 Q4	$202K	Buy	+741	New	+$201K	0.03%	250

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Apollon Financial's CME Position: Q1 2026 in Review

Apollon Financial sold out of CME Group (CME) in Q1 2026, closing a stake of 741 shares — an estimated $202K sold.

Apollon Financial first reported a position in CME in Q4 2025 and held it in 1 quarter. The position peaked at $202K in Q4 2025. 1,799 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Apollon Financial reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
Apollon Financial sold 741 CME Group shares in Q1 2026, an estimated $202K.
Apollon Financial first reported a position in CME Group in Q4 2025 and held it in 1 quarter.
Apollon Financial's CME Group position peaked at $202K in Q4 2025.
1,799 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Apollon Financial's 13F filing for Q1 2026, filed 22 Apr 2026.